Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement

Source Summary

Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio, [...]